Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

QR Code

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

BACKGROUND & AIMS: It is difficult to determine the different stages of non-alcoholic fatty liver disease without the use of invasive liver biopsy. In this study we investigated five non-invasive biomarkers used previously to detect hepatic fibrosis and determined the level of agreement between...

Full description

Bibliographic Details
Main Authors:	Morling, Joanne R., Fallowfield, Jonathan A., Guha, Indra Neil, Nee, Lisa D., Glancy, Stephen, Williamson, Rachel M., Robertson, Christine M., Strachan, Mark W.J., Price, Jackie F.
Format:	Article
Published:	Elsevier 2014
Subjects:	Aged; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Cohort studies; Diabetes Mellitus Type 2; Elasticity imaging techniques; Fatty Liver; Liver Cirrhosis; Non-alcoholic fatty liver disease; Platelet count; Predictive value of tests
Online Access:	https://eprints.nottingham.ac.uk/51981/

Similar Items

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using Transient Elastography
by: Harman, David J., et al.
Published: (2018)

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study
by: Morling, Joanne R., et al.
Published: (2015)

Cholesteryl ester transfer protein gene ploymorphisms increase the risk of fatty liver in females independent of adisposity
by: Adams, L., et al.
Published: (2012)

Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: a randomized crossover study
by: Bawden, Stephen, et al.
Published: (2016)

The identification of chronic liver disease in primary care using non-invasive diagnostics within a novel pathway
by: Harman, David J.
Published: (2017)

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
by: Friedman, Scott L., et al.
Published: (2018)

Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity
by: O'Sullivan, T., et al.
Published: (2014)

The effect of pretreatment of zerumbone on fatty liver following ethanol induced Hepatotoxicity
by: Fakurazi, Sharida, et al.
Published: (2008)

Liver cirrhosis in England--an observational study: are we measuring its burden occurrence correctly?
by: Ratib, Sonia, et al.
Published: (2017)

Iron and Hepatic Carcinogenesis
by: Tirnitz-Parker, Janina, et al.
Published: (2013)

Low serum 25-hydroxyvitamin D concentrations are associated with non-alcoholic fatty liver disease in adolescents independent of adiposity
by: Black, Lucinda, et al.
Published: (2014)

Assessment of dietary factors in patients with nonalcoholic fatty liver disease and an intervention study to investigate the effects of low glycaemic index diet
by: Al-Awadi, Amina
Published: (2023)

Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data
by: Otete, Harmony E., et al.
Published: (2018)

Clinically significant chronic liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
by: Morling, Joanne R., et al.
Published: (2016)

The histomorphological analysis of liver following administration of low doses of diclofenac and ibuprofen
by: Mohanambal, Moorthy, et al.
Published: (2009)

The effect of circulatory dysfunction upon the liver in haemodialysis patients
by: Grant, Claire
Published: (2019)

Examining the effects of short-term energy restriction on liver lipid, metabolism and inflammatory status in severely obese adults
by: Baldry, Emma
Published: (2017)

Exploring the experience of people at-risk of Non-alcoholic Fatty Liver Disease in making and maintaining lifestyle changes
by: Mehta, Rhian Mehta
Published: (2024)

Formation, morphology and function of a 3D hepatocyte-hepatic stellate cell co-culture system
by: Thomas, Robert James
Published: (2006)

Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection
by: He, Jun-Jun, et al.
Published: (2016)

Cytotoxic Effect of Girinimbine on HepG2 Cells
by: Mohan, Suvita Syam
Published: (2011)

Antifibrotic Effect of Transforming Growth Factor Beta 1 Inhibitor Extract from Streptomyces SP.Strain H6552 on Human Hepatic Stellate Cells
by: Lim, Chooi Ling
Published: (2010)

Comparison of hepatoma cell lines and primary human hepatocytes as models to study the development of hepatic steatosis
by: Huggett, Zoe
Published: (2020)

Cloning, Expression and Characterization of Hepatitis B Large Surface Antigen In Yeast System
by: Mohamad Sinang, Fazia
Published: (2010)

Antitumor effects of zerumbone on rat hepatocarcinoma and HEPG2 cells
by: Taha, Manal Mohamed Elhassan
Published: (2011)

The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis
by: Sargeant, Jack A., et al.
Published: (2018)

Antiproliferative effects of zerumbone-hydroxypropyl-ß-cyclodextrin inclusion complex on HepG2 liver cancer cells in vitro
by: Muhammad Nadzri, Nabilah
Published: (2013)

Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017)

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
by: Daniels, Samuel J., et al.
Published: (2018)

Characterization and cytotoxicity of clausenidin from Clausena excavata Burm f. and its effects on cell cycle regulation and apoptosis of liver (hepg2) and colon (ht29) cancer cell lines
by: Waziri, Peter Maitalata
Published: (2017)

Microsphere distribution and radiation dosimetry in human liver following Yttrium-90 microsphere therapy.
by: Campbell, Andrew M.
Published: (2000)

Characterization of human stem cell-derived hepatocytes
by: Abukunna, Fatima
Published: (2018)

Biomarkers to predict advanced liver diseases
by: Alenezi, Yusef
Published: (2024)

Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses
by: Tirnitz-Parker, Nina, et al.
Published: (2014)

Structure and function of the insulin receptor: its role during lactation and foetal development
by: Deleo, Domenica
Published: (1994)

Elucidating feline hepatic lipidosis through serum biochemistry, histopathology and gene expression in the Klang valley stray cats
by: Salleh, Muhammad Fadzly
Published: (2020)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

The role of ethnicity in the increased susceptibility to non-alcoholic fatty liver disease in people of Indian origin
by: Chalmers, Jane
Published: (2021)

Mechanism-based intervention in Non-Alcoholic Fatty Liver Disease: mapping the muscle-liver axis and exploring the effect of L-carnitine on liver fat, insulin sensitivity and mitochondrial energy kinetics
by: Thiagarajan, Prarthana
Published: (2021)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)